Article
CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
Acta diabetologica - 1 Dec 2013
Hyvönen Mervi E, Ihalmo Pekka, Sandholm Niina, Stavarachi Monica, Forsblom Carol, McKnight Amy Jayne, Lajer Maria, Maestroni Anna, Lewis Gareth, Tarnow Lise, Maestroni Silvia, Zerbini Gianpaolo, Parving Hans-Henrik, Maxwell Alexander P, Groop Per-Henrik, Lehtonen Sanna
Abstract excerpt
CD2-associated protein (CD2AP) is essential for podocyte function. CD2AP mutations have been found in patients with focal segmental glomerulosclerosis, a disease histologically resembling diabetic nephropathy and often progressing to end-stage renal disease (ESRD). We hypothesised that variations in the CD2AP gene may contribute to susceptibility to glomerular injury in diabetes and investigated if...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
